Literature DB >> 6333182

The effect of epidermal growth factor on epithelial healing after penetrating keratoplasty in human eyes.

A S Kandarakis, C Page, H E Kaufman.   

Abstract

Two groups of patients were assigned randomly to treatment with epidermal growth factor or placebo after penetrating keratoplasty. In all cases, the epithelium was removed completely from the graft by scrubbing at the close of surgery. One group of patients received topically applied growth factor or placebo in a solution with preservative solution four times a day on the day of surgery and twice a day for two days thereafter. The second group of patients received one-half the concentration of growth factor or placebo in a solution without preservative eight times a day for four days beginning the day before surgery. Healing was assessed twice a day by color photography after instillation of 2% fluorescein; the percent area of the remaining epithelial defect was determined with a planimeter. No therapeutic benefit was demonstrated in the eyes treated with growth factor in either group of patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6333182     DOI: 10.1016/0002-9394(84)90121-1

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  11 in total

1.  Influence of topical human epidermal growth factor on postkeratoplasty re-epithelialisation.

Authors:  M M Dellaert; T A Casey; S Wiffen; J Gordon; P Johnson; A J Geerards; W J Rijneveld; L Remeijer; P G Mulder; W H Beekhuis
Journal:  Br J Ophthalmol       Date:  1997-05       Impact factor: 4.638

2.  [Corneal wound healing. II. Treatment of disorders of wound healing].

Authors:  P W Rieck; U Pleyer
Journal:  Ophthalmologe       Date:  2003-12       Impact factor: 1.059

3.  Antagonizing c-Cbl enhances EGFR-dependent corneal epithelial homeostasis.

Authors:  Jamie S Rush; Michael A Boeving; William L Berry; Brian P Ceresa
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-07-01       Impact factor: 4.799

4.  Epidermal growth factor is a constant component of normal human tear fluid.

Authors:  G B van Setten; L Viinikka; T Tervo; K Pesonen; A Tarkkanen; J Perheentupa
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

Review 5.  Role of galectins in re-epithelialization of wounds.

Authors:  Noorjahan Panjwani
Journal:  Ann Transl Med       Date:  2014-09

Review 6.  Epidermal growth factor in human tear fluid: a minireview.

Authors:  G B van Setten; T Tervo; L Viinikka; J Perheentupa; A Tarkkanen
Journal:  Int Ophthalmol       Date:  1991-11       Impact factor: 2.031

7.  The role of endogenous epidermal growth factor receptor ligands in mediating corneal epithelial homeostasis.

Authors:  Joanne L Peterson; Eric D Phelps; Mark A Doll; Shlomit Schaal; Brian P Ceresa
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-01       Impact factor: 4.799

8.  Epidermal growth factor-like, corneal wound healing substance in mouse tears.

Authors:  O Tsutsumi; A Tsutsumi; T Oka
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

9.  Transforming growth factor-alpha is a constant component of human tear fluid.

Authors:  G van Setten; G Schultz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-09       Impact factor: 3.117

10.  Administration of Menadione, Vitamin K3, Ameliorates Off-Target Effects on Corneal Epithelial Wound Healing Due to Receptor Tyrosine Kinase Inhibition.

Authors:  Jamie S Rush; David P Bingaman; Paul G Chaney; Martin B Wax; Brian P Ceresa
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-11-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.